Home / Health / Estrogen's Silent Role: Saving Women from Fatal UTIs
Estrogen's Silent Role: Saving Women from Fatal UTIs
22 Sep
Summary
- Vaginal estrogen can halve UTI hospitalizations in older women.
- A 2002 FDA warning wrongly discouraged estrogen use for decades.
- Estrogen's decline linked to nearly tripled UTI sepsis deaths in women.
Menopause-induced estrogen decline heightens UTI risks for women, sometimes leading to deadly sepsis. Vaginal estrogen, a readily available and affordable treatment, is proven to prevent recurrent UTIs but has been underprescribed for decades.
A 2002 FDA warning, based on a misinterpretation of the Women's Health Initiative, mistakenly applied to low-dose vaginal estrogen. This led to doctors shying away from prescribing it, impacting two generations of women.
Recent studies, including one analyzing nearly 2 million women, reveal that those aged 55 and older using vaginal estrogen were half as likely to be hospitalized with UTIs and had one-fifth the rates of sepsis and death.
Despite the FDA removing the warning in November 2025, its use remains low. Experts emphasize that vaginal estrogen is crucial for preventing UTIs and sepsis, stating every menopausal woman needs it.
Data from 2017 through 2025 indicated that vaginal estrogen could have saved thousands of lives in the 55-69 age group alone. The underuse of this treatment is attributed to a systemic failure in healthcare and education, rather than patient non-compliance.
This gap in provider training and awareness means many women, like Roselin Shankland who died from a UTI-related infection in late 2023, are not offered this life-saving preventative care. Efforts are underway to improve Medicare coverage and integrate vaginal estrogen into standard care protocols.
